Search research articles
Contact Us
Filters
Showing results (251-260 of 259) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 259 results.
Clinical Drug Investigation
|
January 10, 2017
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
Robert Kimutai, Ahmed M Musa, Simon Njoroge, et al.
Clinical Pharmacokinetics
|
June 9, 2021
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients
Luka Verrest, Monique Wasunna, Gilbert Kokwaro, et al.
Molecular Therapy. Methods & Clinical Development
|
September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis
Brima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Kidney International
|
April 26, 2021
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
Usman J Wudil, Muktar H Aliyu, Heather L Prigmore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2022
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial
Ahmed M Musa, Jane Mbui, Rezika Mohammed, et al.
Plos Neglected Tropical Diseases
|
February 27, 2026
Systemic inflammatory markers of visceral leishmaniasis treatment response in East Africa
Ayenew Addisu, Alice Bayiyana, João L Reis Cunha, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
Widespread transmission in diverse ecotypes challenges visceral leishmaniasis control in East Africa
Eva Iniguez, Mercy Tuluso, Steve Kiplagat, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
December 11, 2025
Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study
Mirza Sharifuzzaman, Ajit Kumar Paul, Md Akteruzzaman, et al.
Plos One
|
June 25, 2026
Spatial distribution of diphtheria cases during the 2022/2023 outbreak in Kano State, Northern Nigeria
Rayyan M Garba, Zainab A Umar, Zainab Abdulkadir, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 259) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 259 results.
Clinical Drug Investigation
|
January 10, 2017
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
Robert Kimutai, Ahmed M Musa, Simon Njoroge, et al.
Clinical Pharmacokinetics
|
June 9, 2021
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients
Luka Verrest, Monique Wasunna, Gilbert Kokwaro, et al.
Molecular Therapy. Methods & Clinical Development
|
September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis
Brima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Kidney International
|
April 26, 2021
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
Usman J Wudil, Muktar H Aliyu, Heather L Prigmore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2022
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial
Ahmed M Musa, Jane Mbui, Rezika Mohammed, et al.
Plos Neglected Tropical Diseases
|
February 27, 2026
Systemic inflammatory markers of visceral leishmaniasis treatment response in East Africa
Ayenew Addisu, Alice Bayiyana, João L Reis Cunha, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
Widespread transmission in diverse ecotypes challenges visceral leishmaniasis control in East Africa
Eva Iniguez, Mercy Tuluso, Steve Kiplagat, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
December 11, 2025
Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study
Mirza Sharifuzzaman, Ajit Kumar Paul, Md Akteruzzaman, et al.
Plos One
|
June 25, 2026
Spatial distribution of diphtheria cases during the 2022/2023 outbreak in Kano State, Northern Nigeria
Rayyan M Garba, Zainab A Umar, Zainab Abdulkadir, et al.
Page
of 26